Skip to main content
  • FDA OKs Impella Heart Pump for Cardiomyopathy with Shock

    Percutaneous devices expand beyond post-MI or procedural shock

    The FDA expanded the approval of the Impella line of heart pumps to include heart failure associated with cardiomyopathy leading to cardiogenic shock, device maker Abiomed announced.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details